Latest News and Press Releases

Fangzhou Inc. and Tencent Healthcare jointly launched a comprehensive “AI+Chronic Disease Management” solution.

Fangzhou was recognized with the “Social Responsibility Golden Bull Award”.

Fangzhou was named an “Outstanding Strategic Health Ecosystem Partner,” recognizing its role in advancing digital innovation in chronic disease management.

Fangzhou was presented with a Generative AI Service Filing Certificate at the first Guangdong Provincial LLM Filing Conference.

Fangzhou and Fosun Pharma plan to build partnership in AI-powered chronic disease management, initially focused on psoriasis and other autoimmune condition

Fangzhou plans to expand its "AI + Weight Management" ecosystem through broader applications, data-driven innovation, and cross-industry collaboration.

Fangzhou's “XingShi” Large Language Model (“XS LLM”) was featured by Nature News.

was recognized as an “Outstanding Growth Story in Hong Kong Stocks”

Fangzhou received the “Excellence Award” at Gilead Sciences, Inc.’s (“Gilead”) 2025 Multi-Channel Conference in Shanghai.

Fangzhou announced the release of its proprietary “XingShi” Large Language Model.